Tardive dyskinesia (TD) is a movement disorder linked to neuroleptics, a type of antipsychotic drug. Some studies suggest 20 to 50% of people taking neuroleptics develop TD during treatment, and it ...

Tardive dyskinesia (TD), a long-term side effect of some antipsychotic medications and other drugs that affect dopamine receptors in the brain, can include several types of involuntary, repetitive ...

People with uncontrolled movement problems can have a harder time doing everyday tasks such as speaking, reading, writing, and cooking, which can cause a loss of independence. This may cause people to ...

Neurocrine Biosciences has shared survey data showing how tardive dyskinesia (TD) affects the ability of patients and ...

(BPT) - Tardive Dyskinesia (TD) Awareness Week (May 3-9, 2026) brings attention to TD and aims to reduce stigma and support those affected by the condition. This important week unites the mental ...

Tardive Dyskinesia TD as a neurological disorder resulting in involuntary repetitive movement disorder as a disease of brain Neurology due to dopamine problems. What have studies said the role vitamin ...

As the annual Tardive Dyskinesia Awareness Week begins again, Neurocrine Biosciences is continuing its work to improve understanding of the condition and available treatments. This time around, the ...

Earlier this month, in the first week of May, many mental health advocates, psychiatrists, and patients around the country observed Tardive Dyskinesia (TD) Awareness Week. Tardive dyskinesia is a ...

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the release of findings from a new survey revealing the significant impact of tardive dyskinesia (TD) on people's ability to work, go to ...